Cytochrome B-245, Alpha Polypeptide
Cytochrome b-245, alpha polypeptide (CYBB), also known as gp91^phox, is a critical component of the NADPH oxidase complex found in phagocytes. This enzyme complex plays a vital role in the body's immune response by producing reactive oxygen species (ROS) that are used to kill invading pathogens. The CYBB gene encodes the gp91^phox subunit, which is essential for the activity of the NADPH oxidase complex.
Function[edit | edit source]
The primary function of cytochrome b-245, alpha polypeptide, is to generate superoxide by transferring electrons from NADPH inside the cell across the membrane and coupling them to molecular oxygen to produce superoxide anion, a potent antimicrobial agent. Superoxide anion is further converted into other reactive oxygen species, which are used by phagocytes to destroy invading pathogens. This process is crucial for the innate immune system's ability to fight infections.
Genetic and Molecular Basis[edit | edit source]
The CYBB gene is located on the X chromosome (Xp21.1), which explains the X-linked inheritance pattern of some diseases associated with CYBB mutations, such as Chronic Granulomatous Disease (CGD). Mutations in the CYBB gene lead to a malfunctioning NADPH oxidase complex, resulting in reduced or absent production of reactive oxygen species. This deficiency severely compromises the immune system's ability to destroy pathogens, making individuals susceptible to recurrent infections and granuloma formation.
Clinical Significance[edit | edit source]
Mutations in the CYBB gene are primarily associated with a form of Chronic Granulomatous Disease (CGD), a rare genetic disorder that affects the immune system. Patients with CGD are highly susceptible to infections by bacteria and fungi due to the inability of their phagocytes to produce bactericidal reactive oxygen species. Management of CGD involves preventing and treating infections and, in some cases, hematopoietic stem cell transplantation.
Diagnosis and Treatment[edit | edit source]
Diagnosis of CGD involves testing for the oxidative burst in phagocytes, typically using the dihydrorhodamine (DHR) flow cytometry test or the nitroblue tetrazolium (NBT) test. Treatment focuses on managing infections through antibiotics, antifungals, and interferon-gamma therapy. Hematopoietic stem cell transplantation offers a potential cure by replacing the defective immune cells with healthy ones.
Research Directions[edit | edit source]
Research on cytochrome b-245, alpha polypeptide, and its role in the NADPH oxidase complex continues to provide insights into the mechanisms of innate immunity and the pathogenesis of CGD. Advances in gene therapy and molecular medicine hold promise for developing more effective treatments for CGD and other diseases resulting from oxidative burst deficiencies.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD